BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10741897)

  • 1. Biology of BCR-ABL.
    Chopra R; Pu QQ; Elefanty AG
    Blood Rev; 1999 Dec; 13(4):211-29. PubMed ID: 10741897
    [No Abstract]   [Full Text] [Related]  

  • 2. The biology of chronic myeloid leukemia.
    Faderl S; Talpaz M; Estrov Z; O'Brien S; Kurzrock R; Kantarjian HM
    N Engl J Med; 1999 Jul; 341(3):164-72. PubMed ID: 10403855
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular mechanisms of Bcr-Abl-induced oncogenesis.
    Gishizky ML
    Cytokines Mol Ther; 1996 Dec; 2(4):251-61. PubMed ID: 9384712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biology of chronic myelogenous leukemia--signaling pathways of initiation and transformation.
    Melo JV; Deininger MW
    Hematol Oncol Clin North Am; 2004 Jun; 18(3):545-68, vii-viii. PubMed ID: 15271392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular biological pathophysiology of chronic myelogenous leukemia].
    Nishimura J
    Fukuoka Igaku Zasshi; 1995 Feb; 86(2):19-23. PubMed ID: 7729779
    [No Abstract]   [Full Text] [Related]  

  • 6. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
    Matolcsy A
    Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex karyotype with a masked Philadelphia translocation and variant BCR-ABL fusion in CML.
    Bakshi SR; Patel BP; Brahmbhatt MM; Trivedi PJ; Gajjar SB; Iyer RR; Parikh EH; Shukla SN; Shah PM
    Cancer Genet Cytogenet; 2009 Mar; 189(2):142-3. PubMed ID: 19215799
    [No Abstract]   [Full Text] [Related]  

  • 8. Typical chronic myelogenous leukemia with e19a2 BCR/ABL transcript. Report of two cases.
    Martínez-López J; Ayala R; Albizua Q
    Haematologica; 2002 Aug; 87(8):ELT35. PubMed ID: 12161380
    [No Abstract]   [Full Text] [Related]  

  • 9. Modeling Philadelphia chromosome positive leukemias.
    Wong S; Witte ON
    Oncogene; 2001 Sep; 20(40):5644-59. PubMed ID: 11607816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCR/ABL rearrangement in Philadelphia chromosome negative CML patients.
    Rerkamnuaychoke B; Jomsawat U; Maneesri N; Apilugsanachit A; Pattanasak N
    J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S70-5. PubMed ID: 10865410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of the BCR/ABL fusion gene in a Philadelphia chromosome-negative chronic myeloid leukaemia: insertion of 5.6 Mb of 9q34 into the BCR region of chromosome 22.
    Valle L; Fernández V; Pérez-Pons C; Sánchez FG; Benítez J; Urioste M
    Hematol Oncol; 2006 Jun; 24(2):86-8. PubMed ID: 16598834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Two Ph chromosome positive chronic myelogenous leukemia patients with rare bcr/abl fusion gene].
    Qin YZ; Liu YR; Li JL; Wang H; Chang Y; Fu JY; Ruan GR; Shi HL; Qiu JY; Lu DP; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):409-12. PubMed ID: 15355693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
    Vefring HK; Gruber FX; Wee L; Hovland R; Hjorth-Hansen H; Gedde Dahl T; Meyer P
    Acta Haematol; 2009; 122(1):11-6. PubMed ID: 19641300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic myeloid leukemia with a rare variant BCR-ABL translocation: t(9;22;21)(q34;q11.2;q11.2).
    Takeuchi M; Katayama Y; Okamura A; Yamamoto K; Shimoyama M; Matsui T
    Cancer Genet Cytogenet; 2007 Nov; 179(1):85-7. PubMed ID: 17981222
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chronic myelogenous leukemia].
    Niikura H
    Ryoikibetsu Shokogun Shirizu; 2000; (32):418-20. PubMed ID: 11212762
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
    Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G
    Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Philadelphia chromosome-positive thrombocythemia without features of chronic myeloid leukemia (CML) in peripheral blood.
    Girodon F; Bailly F; Barry M; Favre B; Carli PM; Mugneret F; Teyssier JR; Maynadié M
    Ann Hematol; 2005 Jun; 84(6):409-10. PubMed ID: 15692837
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
    Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE
    Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
    Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
    Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan.
    Ko BS; Tang JL; Lee FY; Liu MC; Tsai W; Chen YC; Wang CH; Sheng MC; Lin DT; Lin KH; Tien HF
    Am J Hematol; 2002 Dec; 71(4):291-9. PubMed ID: 12447959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.